INO (Inovio Pharmaceuticals Inc) שולי רווח נקי ממכירות

סמל מסחרי של inovio.com (INO)

Inovio Pharmaceuticals (INO) lacks a steady stream of income due to its focus on developing DNA vaccines. The integral net margin indicator on the GURU.Markets daily chart shows that the metric is currently at -23798.90. While unique CELLECTRA patents provide a defensive moat for the business, the company's success and financial stability depend directly on FDA verdicts and clinical trial results.

שולי רווח נקי inovio.com (INO): לתקופה 04.07.2022 - 19.11.2026

פילוחים אנליטיים של חברת Inovio Pharmaceuticals Inc (INO)

- מחיר מניה וקונצנזוס הערכת שווי:
אנליטיקה מסכמת של החברה:inovio.com - INO
מוצר המיוצר על ידי Inovio Pharmaceuticals, Inc.

To select fundamentally resilient assets, an investor must evaluate the efficiency of converting revenue into net income while filtering out market noise. This metric measures the portion of bottom-line income for every dollar earned, which for Inovio Pharmaceuticals (INO) and its government contracts in the DNA medicine sector reflects the actual cost of vaccine development, as clearly demonstrated by a balanced net margin.